Alumis (ALMS) Cash from Financing Activities (2023 - 2025)

Alumis' (ALMS) quarterly Cash from Financing Activities came in at $1.3 million in Q4 2025, up 26260.0% year-on-year from N/an in Q4 2024, and up 26260.0% on a QoQ basis from $5000.0 in Q4 2024.

Alumis (ALMS) Cash from Financing Activities (2023 - 2025) Analysis & Trends

Alumis (ALMS) has 3 years of Cash from Financing Activities data on file, last reported at $1.3 million in Q4 2025.

  • On a quarterly basis, Cash from Financing Activities rose 26260.0% year-over-year to $1.3 million in Q4 2025; TTM through Dec 2025 was $236.5 million, a 51.97% decrease from a year earlier, with the FY2025 full-year figure at $2.1 million, down 99.58% from the prior year.
  • Cash from Financing Activities for Q4 2025 stood at $1.3 million, up from $5000.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for ALMS reached as high as $235.2 million in Q3 2024 and fell as low as $5000.0 in Q4 2024.
  • Historically, Cash from Financing Activities has averaged $74.8 million across 3 years, with a median of $29.7 million in 2023.
  • On a YoY basis, Cash from Financing Activities climbed as much as 500221.28% in 2024 and fell as far as 99.98% in 2024.
  • Year by year, Cash from Financing Activities stood at $29.7 million in 2023, then tumbled by 99.98% to $5000.0 in 2024, then jumped by 26260.0% to $1.3 million in 2025.
  • Per Business Quant data, the three most recent Cash from Financing Activities figures were $1.3 million in Q4 2025, $5000.0 in Q4 2024, and $235.2 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 30.14 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 68.63 Mn
4 NuCana 279.75 Bn 279.75 Bn - 9,311.16
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -538.80 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -802.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 238.74 Mn
10 Alumis 2.41 Bn 2.10 Bn - 1.32 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.32 Mn
Dec 31, 2025 1.32 Mn
Dec 31, 2024 5,000.00
Dec 31, 2024 5,000.00
Sep 30, 2024 235.15 Mn
Sep 30, 2024 235.15 Mn
Jun 30, 2024 128.06 Mn
Jun 30, 2024 128.06 Mn
Mar 31, 2024 129.15 Mn
Mar 31, 2024 129.15 Mn
Dec 31, 2023 29.72 Mn
Dec 31, 2023 29.72 Mn
Sep 30, 2023 47,000.00
Sep 30, 2023 47,000.00